Topic Hub

Age V2 Romosozumab

3 clinically reviewed articles, written and peer-reviewed by the WomanRx.com Medical Team.

3articles

27keywords mapped

2025-01-28latest review

Explore

Age V2 Romosozumab library

Showing 3 of 3 clinical reviews.

Questions2025-01-28

Evenity (Romosozumab) and Children Under 12: What Parents and Clinicians Need to Know

Romosozumab is not approved for pediatric use under age 12. Learn why, what the evidence shows, and which bone treatments are safe for girls and young women.

Read clinical review

Safety2025-01-28

Evenity (Romosozumab) for Women 65 and Older: Activity, Exercise, and Daily Life Considerations

How romosozumab (Evenity) affects physical activity, fall risk, exercise planning, and daily routines for women 65+ on bone-building therapy.

Read clinical review

Safety2025-01-20

Evenity (Romosozumab) for Women 65 and Older: What You Need to Know

How romosozumab works, who benefits most, cardiovascular risks, and what geriatric women should expect from Evenity treatment for osteoporosis.

Read clinical review